News
Bullying a ‘persistent, important’ problem for cardiology trainees
One-third of cardiologist trainees in the U.K. reported experiencing or witnessing bullying in the previous 4-week period in new survey, with the...
News
Cardiologist positive for Omicron after London conference
“Came back from a conference in London. With a mask and 3 Pfizer vaccines I managed to get Omicron.”
News
New CETP inhibitor impresses in LDL lowering
A new lipid-lowering agent, obicetrapib, in a class that had been written off by many, is being developed by a group of academic experts, with new...
News
CABG safe 3 days after stopping ticagrelor: RAPID CABG
A new randomized trial showed similar rates of severe bleeding in patients going to surgery at 3 days and 6 days after stopping the antiplatelet...
News
How applicable is ISCHEMIA trial to U.S. clinical practice?
A new study suggests that less than a third of U.S. patients with stable ischemic heart disease who currently undergo intervention would meet the...
News
Which agent is best for neuromyelitis optica?
Researchers conducted an indirect treatment comparison on the efficacy of the three FDA-approved treatment options for adults with AQP4+ NMOSD.
News
Stem cell transplant benefits in secondary progressive MS
The procedure was associated with a slowing of disability progression and a higher likelihood of disability improvement.
News
Updated MS guidelines advocate earlier, more aggressive treatment
The updated guidelines address the efficacy of disease-modifying therapies, early treatment decisions, disease/treatment response monitoring and...
News
MS and (non-COVID) vaccinations: consensus recommendations
The document proposes a global vaccination strategy for the general MS patient population and selected subpopulations.
News
ECTRIMS/EAN statement on COVID-19 vaccination in patients with MS
The statement concludes that the COVID-19 vaccines that are currently available are safe for patients with MS.
News
Ublituximab improves functional MS score: New ULTIMATE analysis
Trial data are being used to support a recent approval application to the FDA for ublituximab to treat patients with relapsing remitting MS.
News
COVID-19 vaccination in MS: Lower response on certain medications
Currently approved COVID-19 vaccines appear safe in patients with MS and are effective in most patients.
News
USPSTF rules out aspirin for over 60s in primary CVD prevention
New draft recommendations from the U.S. Preventive Services Task Force (USPSTF) on the use of aspirin for the primary prevention of cardiovascular...
News
CVST after COVID-19 vaccine: New data confirm high mortality rate
“This is the biggest series, and as an international series, it gives a broader perspective from a larger range of countries.”